News

Response Pharmaceuticals Announces Positive Top-Line Results From Phase 2 Study of RDX-002 in Post-GLP-1 Management

RDX-002, a novel iMTP inhibitor, showed promising results in a Ph2 study, reducing blood fat and weight regain after GLP-1 ...
The Pharma Letter2h

Response offers positive Phase II data for post-GLP-1 obesity

US biotech Response Pharmaceuticals (Nasdaq: RSPN) has unveiled top-line Phase II results for its experimental obesity ...
Applied Clinical Trials Online19h

Response’s Investigational Small Molecule Inhibitor Shows Promising Post-GLP-1 Weight Management, Cardiometabolic Benefits

Results from a Phase II trial (NCT06640972) showed that patients treated with RDX-002 experienced significant reductions in ...
GlobalData on MSN20h

Response’s post-GLP-1RA drug reduces weight rebound in Phase II

Response Pharmaceuticals’ drug has helped reduce the amount of weight a patient regains after treatment with glucagon-like ...
Fierce Biotech1d

Response’s ex-Sanofi asset hits midphase goal in post-GLP-1 patients

Response Pharmaceuticals has shared phase 2 data in post-GLP-1 patients, linking its ex-Sanofi asset to reductions in ...
Cars6d

New and used 2025 Acura RDX Technology Package for sale near

Shop 2025 Acura RDX Technology Package vehicles in Westford, MA for sale at Cars.com. Research, compare, and save listings, or contact sellers directly from 6 2025 RDX models in Westford, MA.
BBC6d

BBC Audio | Understand | Derailed: The Story of HS2 | 1. The Railwayman

HS2's story begins with a blank piece of paper.